DBV Technologies S.A. ADR (DBVT)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Daniel Tassé
Employees:
80
177-181 AVENUE PIERRE BROSSOLETTE, MONTROUGE, FRANCE 92120
33(0)155427878

DBV Technologies S.A. engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. Its other earlier stage research programs include a vaccine for the respiratory syncytial virus.

Data derived from most recent annual or quarterly report
Market Cap 244.757 Million Shares Outstanding188.274 Million Avg 30-day Volume 67.426 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.35
Price to Revenue34.1301 Debt to Equity0.0 EBITDA-89.996 Million
Price to Book Value1.0912 Operating Margin-1947.7813999999998 Enterprise Value5.256 Million
Current Ratio5.859 EPS Growth0.195 Quick Ratio5.213
1 Yr BETA 0.8616 52-week High/Low 2.37 / 1.08 Profit Margin-1929.7848
Operating Cash Flow Growth-68.9239 Free Cash Flow to Firm (FCFF) TTM -63.306 Million Free Cash Flow to Equity (FCFE) TTM-72.104 Million
Altman Z-Score0.0278
View SEC Filings from DBVT instead.

View recent insider trading info

DBV Technologies S.A. ADR YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding DBVT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DBVT

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-08-14 by MOHIDEEN PHARIS
  • 4: filed on 2023-08-14 by ROBITAILLE SEBASTIEN
  • 3: filed on 2022-10-06 by GUYOT-CAPARROS DANIELE
  • 4: filed on 2022-06-13 by BAKER JULIAN
  • 4: filed on 2021-11-24 by TASSE DANIEL
  • 4: filed on 2021-11-24 by MOHIDEEN PHARIS
  • 4: filed on 2021-11-24 by ROBITAILLE SEBASTIEN
  • 4: filed on 2021-06-11 by SOLAND DANIEL B
  • 4: filed on 2021-06-11 by NDU ADORA
  • 4: filed on 2021-06-11 by MORRIS TIMOTHY E

    • Events (8k)

  • 8-K: filed on 2023-07-31:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-11:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-20:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-13:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-03-13:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2023-03-07:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-23:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    27 Thousand total shares from 2 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    MORRIS TIMOTHY E

    • Director
    		 12,000 2023-08-25 1

    SOLAND DANIEL B

    • Director
    		 20,000 2023-08-01 1

    TASSE DANIEL CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 0 2022-11-21 1

    ROBITAILLE SEBASTIEN CHIEF FINANCIAL OFFICER

    • Officer
    		 36,500 2022-11-21 1

    GUYOT-CAPARROS DANIELE

    • Director
    		 0 2022-10-03 1

    MOHIDEEN PHARIS CHIEF MEDICAL OFFICER

    • Officer
    		 49,439 2022-07-29 0

    BAKER BROS. ADVISORS LP

    667, L.P.

    BAKER JULIAN

    BAKER FELIX

    BAKER BROS. ADVISORS (GP) LLC

    BAKER BROTHERS LIFE SCIENCES LP

    • Director
    • 10% Owner
    		 30,775,302 2022-06-13 0

    DE ROSEN MICHEL

    • Director
    		 6,837 2021-06-10 0

    RAO MADDURI RAVIN

    • Director
    		 6,837 2021-06-10 0

    MONGES VIVIANE

    • Director
    		 5,000 2021-06-10 0

    NDU ADORA

    • Director
    		 6,837 2021-06-10 0

    O'NEILL JULIE

    • Director
    		 0 2021-01-01 0

    GOLLER MICHAEL

    • Director
    		 0 2021-01-01 0

    FERRERE MAILYS

    • Director
    		 0 2021-01-01 0

    BJERKE TORBJORN

    • Director
    		 35,925 2021-01-01 0

    GIRAUT CLAIRE

    • Director
    		 0 2021-01-01 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    MORRIS TIMOTHY E - Director

    		2023-08-28 16:35:24 -0400 2023-08-25 P 12,000 $1.52 a 12,000 direct -8.9286 -1.7857 4.1667 5 -8.9286 2

    SOLAND DANIEL B - Director

    		2023-08-03 16:40:44 -0400 2023-08-01 P 15,000 $1.62 a 20,000 direct 3.8961 -0.6494 -9.0909 13.6364 22 -9.0909 31

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    DBV TECHNOLOGIES SA-SPON ADR DBVT 2023-09-27 16:15:05 UTC -26.7953 32.1153 150000
    DBV TECHNOLOGIES SA-SPON ADR DBVT 2023-09-27 15:45:04 UTC -26.7953 32.1153 150000
    DBV TECHNOLOGIES SA-SPON ADR DBVT 2023-09-27 15:15:03 UTC -26.7953 32.1153 150000
    DBV TECHNOLOGIES SA-SPON ADR DBVT 2023-09-27 14:45:03 UTC -26.7953 32.1153 150000
    DBV TECHNOLOGIES SA-SPON ADR DBVT 2023-09-27 14:15:03 UTC -26.7953 32.1153 150000
    DBV TECHNOLOGIES SA-SPON ADR DBVT 2023-09-27 13:45:03 UTC -28.315 33.635 150000
    DBV TECHNOLOGIES SA-SPON ADR DBVT 2023-09-27 13:15:05 UTC -28.315 33.635 150000
    DBV TECHNOLOGIES SA-SPON ADR DBVT 2023-09-27 12:45:05 UTC -28.315 33.635 95000
    DBV TECHNOLOGIES SA-SPON ADR DBVT 2023-09-26 22:15:04 UTC -28.0292 33.3492 200000
    DBV TECHNOLOGIES SA-SPON ADR DBVT 2023-09-26 21:45:04 UTC -28.0292 33.3492 200000
    DBV TECHNOLOGIES SA-SPON ADR DBVT 2023-09-26 21:15:04 UTC -28.0292 33.3492 200000
    DBV TECHNOLOGIES SA-SPON ADR DBVT 2023-09-26 20:45:03 UTC -28.0292 33.3492 200000
    DBV TECHNOLOGIES SA-SPON ADR DBVT 2023-09-26 20:15:05 UTC -28.0292 33.3492 200000
    DBV TECHNOLOGIES SA-SPON ADR DBVT 2023-09-26 19:45:04 UTC -28.0292 33.3492 200000
    DBV TECHNOLOGIES SA-SPON ADR DBVT 2023-09-26 19:15:04 UTC -28.0292 33.3492 200000
    DBV TECHNOLOGIES SA-SPON ADR DBVT 2023-09-26 18:45:05 UTC -28.0292 33.3492 200000
    DBV TECHNOLOGIES SA-SPON ADR DBVT 2023-09-26 18:15:03 UTC -28.0292 33.3492 200000
    DBV TECHNOLOGIES SA-SPON ADR DBVT 2023-09-26 17:45:04 UTC -28.0292 33.3492 200000
    DBV TECHNOLOGIES SA-SPON ADR DBVT 2023-09-26 17:15:04 UTC -28.0292 33.3492 200000
    DBV TECHNOLOGIES SA-SPON ADR DBVT 2023-09-26 16:45:03 UTC -28.0292 33.3492 200000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments